Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Change in Interest Receivables (2024 - 2025)

Perspective Therapeutics' Change in Interest Receivables history spans 2 years, with the latest figure at $19000.0 for Q3 2025.

  • For Q3 2025, Change in Interest Receivables changed N/A year-over-year to $19000.0; the TTM value through Sep 2025 reached $1.2 million, changed N/A, while the annual FY2024 figure was $880000.0, N/A changed from the prior year.
  • Change in Interest Receivables for Q3 2025 was $19000.0 at Perspective Therapeutics, down from $212000.0 in the prior quarter.
  • Across five years, Change in Interest Receivables topped out at $880000.0 in Q4 2024 and bottomed at $19000.0 in Q3 2025.